INCOME STATEMENT
Jagsonpal Pharmaceuticals Ltd.
BSE
Jun 16
231.05
-2.00 ( -0.86%)
Volume
5463
Prev. Close
233.05
Open Price
230.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 16
231.09
-1.86 ( -0.80%)
Volume
74474
Prev. Close
232.95
Open Price
230.61
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE048B01035
|
Market Cap. ( ₹ in Cr. )
|
1537.36
|
P/BV
|
7.80
|
Book Value ( ₹ )
|
29.64
|
BSE Code
|
507789
|
52 Week High/Low ( ₹ )
|
328/130
|
FV/ML
|
2/1
|
P/E(X)
|
27.77
|
NSE Code
|
JAGSNPHARMEQ
|
Book Closure
|
08/01/2025
|
EPS ( ₹ )
|
8.32
|
Div Yield (%)
|
1.08
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 2.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 |
Total Operating Revenues | 268.72 | 208.70 | 236.71 | 226.10 | 187.95 |
| | | | | |
Other Income | 8.19 | 9.28 | 5.73 | 3.34 | 4.39 |
Total Revenue | 276.91 | 217.98 | 242.45 | 229.43 | 192.34 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 18.34 | 22.10 | 31.21 | 40.42 | 38.63 |
Purchase Of Stock-In Trade | 80.22 | 53.98 | 57.59 | 49.75 | 36.86 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -2.13 | 3.90 | 4.30 | 5.61 | 5.28 |
Employee Benefit Expenses | 64.13 | 48.49 | 56.42 | 57.68 | 53.98 |
Finance Costs | 0.96 | 0.81 | 0.41 | 0.29 | 1.09 |
Provisions And Contingencies | 0.00 | 0.77 | 0.00 | 0.00 | 0.00 |
Depreciation And Amortisation Expenses | 8.13 | 1.66 | 1.21 | 1.53 | 0.51 |
Other Expenses | 57.08 | 56.40 | 53.04 | 46.84 | 34.11 |
Total Expenses | 226.73 | 188.11 | 204.18 | 202.11 | 170.47 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 50.17 | 29.87 | 38.27 | 27.32 | 21.87 |
| | | | | |
Exceptional Items | 19.69 | 0.00 | -3.46 | 0.00 | 0.00 |
Profit/Loss Before Tax | 69.86 | 29.87 | 34.81 | 27.32 | 21.87 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 14.50 | 7.56 | 7.63 | 7.40 | 6.05 |
Deferred Tax | 0.00 | -0.15 | 0.46 | 0.33 | -1.23 |
Total Tax Expenses | 14.50 | 7.41 | 8.09 | 7.73 | 4.81 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 |
| | | | | |
Profit/Loss From Continuing Operations | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 |
| | | | | |
Profit/Loss For The Period | 55.36 | 22.46 | 26.72 | 19.59 | 17.06 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 8.26 | 8.49 | 10.20 | 7.48 | 6.51 |
Diluted EPS (Rs.) | 8.22 | 8.46 | 10.20 | 7.48 | 6.51 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 13.10 | 0.00 | 10.48 | 2.62 |
Equity Dividend Rate (%) | 125.00 | 100.00 | 100.00 | 80.00 | 20.00 |